Diabetes experts make new recommendations to treat high blood glucose in people with type 2 diabetes. New guidelines focus on factors such as language use, sleep, and...

Less-than-ideal blood glucose levels can cause nerve and circulatory damage in the ears over time and result in hearing loss and, potentially, balance issues. There are...

Resilience is the ability to bounce back from adversity. From a data control associate to therapist to nurse practitioner, three women practice resiliency to navigate...

Mounjaro, a drug approved in 2022 to treat type 2 diabetes, has also shown remarkable weight-loss effects, reducing trial participants’ weight by over 20%. Regulators...

The first large-scale launch of the highly anticipated Dexcom G7 continuous glucose monitor (CGM) has officially begun. The next-generation CGM is now available in...

Managing your Time in Range (TIR) can be challenging, but there are several apps you can download to help you. In this article, we cover 14 apps you may want to check...

About 200 million people with diabetes around the world require daily insulin. Once-weekly basal insulins, if approved, could require fewer injections and potentially...

During the European Association for the Study of Diabetes 2022 annual meeting, diaTribe hosted its ninth annual “Solvable Problems in Diabetes” panel discussion, where...

A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...

The term “type 2 diabetes remission” continues to spark debate in the diabetes community. At the EASD 2022 annual conference in Stockholm, experts explored this concept...

diaTribe is excited to bring you additional expanded coverage from the EASD 2022 conference! Hear from leading clinicians and researchers around the world on insights...

Researchers presented on the exciting weight loss efficacy of tirzepatide. While tirzepatide has not yet been approved for weight loss, the SURMOUNT clinical trial...

The Diabetes Education Study Group (DESG) hosted a panel at this year’s EASD in which panelists provided an overview of recent evidence supporting education about...

An actively recruiting clinical trial is seeking to evaluate a new drug to treat diabetic kidney disease (DKD). This new injectable drug will be given alongside Farxiga...

Having diabetes puts you at risk for problems with your feet. There are steps you can take to keep your feet healthy as recommended in the latest ADA Standards of Care.

The latest advances in diabetes care have led to several new tools to help people with type 2 diabetes lower their glucose, lose weight, and prevent complications. From...

If you have type 2 diabetes, reaching and maintaining a healthy weight is crucial for managing your blood sugar and preventing complications. Find out about the...

Impressive results from the DELIVER trial show that dapagliflozin (Farxiga), a SGLT-2 inhibitor, could be used to treat all types of heart failure, a common diabetes...

Having diabetes puts you at risk for nerve damage that can affect digestion, breathing, or even blood pressure – a condition known as autonomic neuropathy. Here are...

Encouraging trial results from Novo Nordisk show that a new combination therapy in development could help people lower their A1C and weight dramatically. With the...